Underlying issues in bioaccessibility and bioavailability
In: Ecotoxicology and Environmental Safety, Band 56, Heft 1, S. 52-62
6 Ergebnisse
Sortierung:
In: Ecotoxicology and Environmental Safety, Band 56, Heft 1, S. 52-62
In: Umweltwissenschaften und Schadstoff-Forschung: UWSF ; Zeitschrift für Umweltchemie und Ökotoxikologie ; Organ des Verbandes für Geoökologie in Deutschland (VGöD) und der Eco-Informa, Band 22, Heft 5, S. 517-528
ISSN: 1865-5084
In: Environmental sciences Europe: ESEU, Band 32, Heft 1
ISSN: 2190-4715
AbstractThe European Medicines Agency (EMA) regards the potential risks of human medicinal products to the environment and their impacts are assessed, as well as management to limit this impact. Hazard assessment of novel materials, which differ from conventional chemicals, e.g. nanobiomaterials, poses testing challenges and represents a work-in-progress with much focus on the optimization of required methodologies. For this work-in-progress, we here highlight where changes/updates are required in relation to the main elements for international testing based on OECD guidelines, supported by knowledge from the nanotoxicity area. The outline describes two major sections, nanobiomaterials and environmental hazards, including its challenges and learned lessons, with recommendations for implementation in OECD guidelines. Finally, the way forward via a testing strategy is described.
In: Ecotoxicology and Environmental Safety, Band 56, Heft 1, S. 6-19
In: Environmental Sciences Europe, Band 22, Heft 1, S. 63-67
ISSN: 2190-4715
© 2016 American Chemical Society. Engineered nanomaterials (ENMs) are increasingly entering the environment with uncertain consequences including potential ecological effects. Various research communities view differently whether ecotoxicological testing of ENMs should be conducted using environmentally relevant concentrations - where observing outcomes is difficult - versus higher ENM doses, where responses are observable. What exposure conditions are typically used in assessing ENM hazards to populations? What conditions are used to test ecosystem-scale hazards? What is known regarding actual ENMs in the environment, via measurements or modeling simulations? How should exposure conditions, ENM transformation, dose, and body burden be used in interpreting biological and computational findings for assessing risks? These questions were addressed in the context of this critical review. As a result, three main recommendations emerged. First, researchers should improve ecotoxicology of ENMs by choosing test end points, duration, and study conditions - including ENM test concentrations - that align with realistic exposure scenarios. Second, testing should proceed via tiers with iterative feedback that informs experiments at other levels of biological organization. Finally, environmental realism in ENM hazard assessments should involve greater coordination among ENM quantitative analysts, exposure modelers, and ecotoxicologists, across government, industry, and academia.
BASE